Evidence map›Paper›PMID 41960203›Full record

ArticleStatistica Sinica2023

DEFINING AND ESTIMATING PRINCIPAL STRATUM SPECIFIC NATURAL MEDIATION EFFECTS WITH SEMI-COMPETING RISKS DATA.

Fei Gao, Fan Xia, K C G Chan

Abstract read
In one paragraph

Article in Statistica Sinica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fei GaoVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Fan XiaDepartment of Epidemiology & Biostatistics, University of California at San Francisco, San Francisco, CA 94158, USA.
K C G ChanDepartment of Biostatistics, University of Washington, Seattle, WA 98195, USA.

Funding

NATIONAL ALZHEIMERS COORDINATING CENTER (NACC)U01AG016976 · NIA · UNIVERSITY OF WASHINGTON · PI KUKULL, WALTER ANTHONY · 1999 to 2020
$72.8M
Methods of reduced-cost designs for studying disease incidence and fatality risksR01HL122212 · NHLBI · UNIVERSITY OF WASHINGTON · PI CHAN, KWUN CHUEN GARY · 2014 to 2017
$2.2M
NHLBI NIH HHS R01 HL122212NIA NIH HHS U01 AG016976
6 · The paper itself

Abstract

In many medical studies, an ultimate failure event, such as death, is likely to be affected by the occurrence and timing of other intermediate clinical events. Both event times are subject to censoring by loss-to-follow-up, but the nonterminal event may be further censored by the occurrence of the primary outcome, but not vice versa. To study the effect of an intervention on both events, the intermediate event may be viewed as a mediator. However, the conventional definitions of direct and indirect effects do not apply, because of the semi-competing risks data structure. We define three principal strata based on whether the potential intermediate event occurs before the potential failure event. This allows us to properly define direct and indirect effects in one stratum, and define total effects for all strata. We discuss the identification conditions for the stratum-specific effects, and propose a semiparametric estimator based on a multivariate logistic stratum membership model and within-stratum proportional hazards models for the event times. By treating the unobserved stratum membership as a latent variable, we propose an expectation-maximization algorithm for the computation. We study the asymptotic properties of the estimators using modern empirical process theory and examine the performance of the estimators in numerical studies.

Indexed as

Illness-death modelmissing dataprincipal stratificationproportional hazards modelsurvival analysis

Identifiers

PMID41960203
PMCPMC13061409

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.